Artivion (AORT) Other Operating Expenses (2010 - 2025)

Artivion's (AORT) quarterly Other Operating Expenses came in at $3.5 million in Q4 2025, little changed on a QoQ basis from $3.5 million in Q3 2025.

Artivion (AORT) Other Operating Expenses (2010 - 2025) Analysis & Trends

Artivion (AORT) has 6 years of Other Operating Expenses data on file, last reported at $3.5 million in Q4 2025.

Quarterly Other Operating Expenses changed N/A year-over-year to $3.5 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $7.0 million (changed N/A YoY) and the FY2025 annual result came in at $7.0 million, changed N/A from the prior year.
Other Operating Expenses held at $3.5 million in Q4 2025, from $3.5 million in the prior quarter.
In the past five years, Other Operating Expenses ranged from a high of $15.9 million in Q3 2021 to a low of -$44.3 million in Q2 2021.
A 3-year average of -$8.3 million and a median of $3.5 million in 2025 frame the typical range for Other Operating Expenses.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	200.51 Bn	194.91 Bn	7.27 Bn
2	Stryker	129.96 Bn	126.48 Bn	4.50 Bn
3	Medtronic	120.18 Bn	110.96 Bn	6.41 Bn
4	Boston Scientific	74.28 Bn	73.74 Bn	3.85 Bn
5	Edwards Lifesciences	52.75 Bn	48.50 Bn	1.35 Bn
6	Dexcom	34.67 Bn	32.73 Bn	830.00 Mn
7	GE HealthCare Technologies	34.23 Bn	32.12 Bn	2.18 Bn
8	Koninklijke Philips	26.46 Bn	23.14 Bn	4.55 Bn
9	Steris	23.30 Bn	22.82 Bn	684.20 Mn
10	Artivion	1.38 Bn	1.30 Bn	80.52 Mn

Download Data